Baseline patient-reported outcomes in light-chain amyloidosis patients enrolled on an interventional clinical trial. Amyloid 2019;26(sup1):87-88
Date
07/26/2019Pubmed ID
31343353Pubmed Central ID
PMC7108667DOI
10.1080/13506129.2019.1582019Scopus ID
2-s2.0-85069630470 (requires institutional sign-in at Scopus site) 2 CitationsAuthor List
D'Souza A, Hari P, Pasquini M, Jacobsen K, Flynn KEAuthors
Anita D'Souza MD Associate Professor in the Medicine department at Medical College of WisconsinKathryn Eve Flynn PhD Vice Chair, Professor in the Medicine department at Medical College of Wisconsin
Parameswaran Hari MD Adjunct Professor in the Medicine department at Medical College of Wisconsin
Marcelo C. Pasquini MD, MS Professor in the Medicine department at Medical College of Wisconsin
MESH terms used to index this publication - Major topics in bold
AgedAmyloidosis
Clinical Trials as Topic
Female
Humans
Immunoglobulin Light Chains
Male
Middle Aged
Patient Reported Outcome Measures